Woman Dies After Using Weight-Loss Drug In U.K.’s First Case
A 58-year-old nurse from Scotland has died after taking two doses of weight-loss drug tirzepatide, also known as Mounjaro or Zepbound.
Medicaid covers GLP-1 weight-loss drugs in just 13 states
Only 13 states currently allow Medicaid to cover treatment of obesity using glucagon-like peptide-1 agonist (GLP-1) medications, researchers said.
Microdosing Ozempic? Why some people are playing doctor with weight-loss drugs
As demand for popular weight-loss drugs like Wegovy and Zepbound skyrockets, patients are taking dosage amounts into their own hands.
Map Shows States Where Weight Loss Drugs are Most Popular
Kentucky, Alaska and Alabama are the three states where weight loss drugs are most used, and Hawaii, Arizona and Colorado sit at the other end of the spectrum, a report has revealed.
4 Ways to Prevent Muscle Loss on Ozempic & Other Weight Loss GLP-1 Medications
You can’t go far lately without seeing news and social media coverage of GLP-1 (glucagon-like peptide-1) receptor agonists like Ozempic®, Wegovy®, Mounjaro®, and Zepbound®.
A new weight loss drug could beat Ozempic's side effect problem
The Denmark-based drug maker Zealand Pharma said Tuesday that its experimental weight-loss drug could help patients lose pounds with fewer side effects than current anti-obesity medications on the market.
Concern over counterfeit versions of weight loss drugs like Ozempic
Experts say as drugs like Ozempic and Wegovy grow in popularity, it presents the chance for fake versions to make their way onto the market.
You Can Now Get Prescription Weight Loss Drugs Like Ozempic From An Online Telehealth Visit. But Is It Safe?
These drugs have also been in and out of shortage, making it tough to get your hands on Ozempic and similar medications—if you can afford it. Semaglutide medications like Ozempic and Wegovy are also reportedly getting closer to moving off the shortages list,
Dallas Morning News on MSN2d
FDA adds new warning to weight loss drugs including Wegovy
The FDA is warning that patients taking GLP-1s may be at a higher risk of inhaling fluid into their lungs while under ...
Outsourcing-pharma9d
Competitors race to launch GLP-1 drugs amid soaring weight loss demand
Demand for weight loss drugs targeting GLP-1 has exploded in recent years, leading to disruptions in supply chains. Here are ...
Soap Central on MSN10d
Smoothie King launches new menu for Ozempic and other GLP-1 weight loss supplement users
On October 29, Smoothie King announced the launch of new smoothies that support individuals with weight management goals.
Medpage Today on MSN2d
Zepbound's Weight Loss, Cardiometabolic Benefits Hold Up at 3 Years
SAN ANTONIO -- Patients with overweight or obesity lost an average one-fifth of their body weight with the highest dose of ...
Medscape10d
GLP-1 Use Presurgery Safe but No Weight Loss Boost
Use of glucagon-like peptide 1 receptor agonists (GLP-1 RAs) prior to bariatric surgery was safe but wasn’t associated with ...
UK Nurse's Death Linked To Weight Loss Jab: Report
The death of a nurse has been linked to a weight loss jab due to be assessed by the UK government as a way of easing pressure on the overburdened state-run National Health Service, the BBC reported on ...
Novo Nordisk aware of reports 10 people taking compounded weight-loss drug copies died
Novo Nordisk said on Wednesday it was aware of reports of 10 deaths and 100 hospitalisations of people who had taken compounded copies of its weight-loss and diabetes drugs. U.S. regulations allow ...